Vaughn Bryan T
EVP and President, Diagnostics
Vaughn Bryan T has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, Vaughn Bryan T is listed as EVP and President, Diagnostics at LABCORP HOLDINGS INC. Inside the rolling window, Vaughn Bryan T reported no open-market purchases and 1 open-market sale totaling $67K in LH.
Companies traded
Other insiders at LH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vaughn Bryan T made?
Vaughn Bryan T has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Vaughn Bryan T trade?
Vaughn Bryan T has filed SEC Form 4 disclosures for 1 company, including LH.
When was Vaughn Bryan T's most recent SEC Form 4 filing?
Vaughn Bryan T's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is Vaughn Bryan T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Vaughn Bryan T is listed as EVP and President, Diagnostics.
What is Vaughn Bryan T's total buy and sell value in the current window?
Inside the rolling retention window, Vaughn Bryan T bought $0 and sold $67K based on SEC Form 4 filings.
What was Vaughn Bryan T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 234 LH shares on 2026-07-02, worth $67K, per SEC Form 4 filings.